GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive NGS Genetic DNA Test
Introduction
The GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive NGS Genetic DNA Test is a specialized diagnostic tool designed to identify genetic mutations associated with Spinocerebellar Ataxia Type 18 (SCA18). This condition is characterized by progressive problems with coordination and balance, leading to significant challenges in daily living. Understanding your genetic predisposition is essential for early intervention and management.
What the Test Measures
This genetic test detects mutations in the GRID2 gene, which are linked to autosomal recessive forms of Spinocerebellar Ataxia. By analyzing the genetic material, healthcare professionals can determine if an individual carries mutations that may lead to the development of SCA18.
Who Should Consider This Test
This test is particularly recommended for individuals with:
- A family history of Spinocerebellar Ataxia or other neurological disorders.
- Symptoms of coordination issues, balance problems, or unexplained neurological symptoms.
- Risk factors associated with genetic conditions.
Consultation with a neurologist or genetic counselor is advised to assess the need for this test.
Benefits of Taking the Test
Taking the GRID2 Gene Spinocerebellar Ataxia Type 18 test offers several benefits:
- Early identification of genetic risks, allowing for proactive management and treatment options.
- Informed decision-making regarding family planning and potential health risks.
- Access to tailored medical care and support based on genetic findings.
Understanding Your Results
After completing the test, results will be available within 3 to 4 weeks. A genetic counselor will help interpret the findings, providing clarity on whether any mutations were detected and what that means for your health. It’s essential to understand the implications of your results for yourself and your family.
Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today!
Don’t wait to understand your genetic health. Book the GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive NGS Genetic DNA Test today. For inquiries or to schedule your appointment, please call or WhatsApp us at +2348077798758.
